Filler era offers new options, challenges

Waikoloa, Hawaii - The U.S. Food and Drug Administration's recent approval of the cosmetic dermal filler Restylane (Medicis) indicates the beginning of a new phase for dermatologists due to the enhanced benefits it offers patients, according to Mark G. Rubin, M.D.

Related Videos
View All
© 2023 MJH Life Sciences

All rights reserved.